Oxford Science Enterprises plc

https://www.oxfordscienceenterprises.com

LinkedIn: https://linkedin.com/company/oxford-science-enterprises

Oxford Science Enterprises (OSE) is an independent, billion-pound investment company, created in 2015 to found, fund and build transformational businesses via its unique partnership with the University of Oxford, the world’s #1 research university. This partnership enables OSE to work with the brightest academic minds tackling the world’s toughest challenges and guarantees unrivalled access to their scientific research. In collaboration with its global network of entrepreneurs and advisers, OSE goes well beyond funding to shape and nurture these complex ideas into successful businesses. Actively focused on a core portfolio of around 40 companies spanning three high-growth, high-impact sectors – Life Sciences, Health Tech, and Deep Tech – the company adopts a flexible, long-term investment approach, recognising the path from ground-breaking research to global markets takes time and resilience. To date, OSE has invested £0.5 billion in over 80 ambitious companies built on Oxford science, helping progress 28 from seed to Series A, and 22 to Series B and beyond, including 2 IPOs and 7 trade sales. A key player in Oxford’s entrepreneurial ecosystem, OSE is highly motivated to foster an environment that catalyses pioneering research and steers it to commercial success. *

	Start	2015-05-01 established pred
	Group	Oxford Science Enterprises (Group)
	Predecessor	Oxford Sciences Innovation plc (OSI)
	Industry	IP services
	Industry 2	venture capital
	Person	Dormandy, Alexis (Univ Oxford 202108 CEO of OSI)
	Person 2	McLean, Andrew (Univ Oxford 201906 Head of Life Sciences 201712 Principal at Oxford Sciences Innovation)

	Region	Oxford, Oxfordshire
	Country	United Kingdom (GB)
	Street	46 Woodstock Road
	City	OX22 6HT Oxford, Oxfordshire
		Address record changed: 2024-01-05

Basic data	Employees	n. a.
	Currency	USD
	Annual sales	800,000,000 (capital, evergreen (2020) 2020-12-09)

		* Document for »About Section«: Oxford Science Enterprises plc. (2/7/23). "Press Release: Oxford Science Enterprises Strengthens Life Sciences Investment Team with Appointment of Sanne de Jongh as Partner". Oxford.

		Record changed: 2024-07-04